Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
NETSCOUT
NTCT
$2.88B
| $2.64M | ﹤0.01% |
122,096
+8,378
| +7% | +$182K |
|
|
LB
5027
CALL
LandBridge Co
LB
$2.24B
| $2.64M | ﹤0.01% |
+40,900
| New | +$2.46M |
|
5028
CALL
Procept Biorobotics
PRCT
$1.24B
| $2.64M | ﹤0.01% |
32,800
+6,000
| +22% | +$513K |
|
5029
PUT
InMode
INMD
$872M
| $2.64M | ﹤0.01% |
157,800
-2,400
| -1% | -$42.6K |
|
5030
CALL
iShares Global Clean Energy ETF
ICLN
$2.09B
| $2.63M | ﹤0.01% |
231,500
-222,300
| -49% | -$2.81M |
|
5031
CALL
First Majestic Silver
AG
$9.49B
| $2.63M | ﹤0.01% |
479,600
-82,200
| -15% | -$531K |
|
5032
Century Communities
CCS
$2.01B
| $2.63M | ﹤0.01% |
35,872
-20,687
| -37% | -$1.84M |
|
5033
GoodRx Holdings
GDRX
$1.27B
| $2.63M | ﹤0.01% |
565,016
+329,622
| +140% | +$1.81M |
|
5034
Orthofix Medical
OFIX
$421M
| $2.63M | ﹤0.01% |
150,443
-137,213
| -48% | -$2.39M |
|
5035
PUT
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.38B
| $2.63M | ﹤0.01% |
10,800
-2,300
| -18% | -$538K |
|
5036
Akebia Therapeutics
AKBA
$242M
| $2.63M | ﹤0.01% |
+1,382,146
| New | +$2.4M |
|
5037
CALL
Newell Brands
NWL
$2.66B
| $2.63M | ﹤0.01% |
263,600
+162,900
| +162% | +$1.48M |
|
5038
Capital Southwest
CSWC
$1.59B
| $2.63M | ﹤0.01% |
120,317
+101,092
| +526% | +$2.38M |
|
5039
CALL
Ingersoll Rand
IR
$32.3B
| $2.62M | ﹤0.01% |
29,000
-91,800
| -76% | -$9.14M |
|
|
ACLX
5040
CALL
DELISTED
Arcellx
ACLX
| $2.62M | ﹤0.01% |
34,200
+3,000
| +10% | +$259K |
|
5041
CALL
Carter's
CRI
$1.42B
| $2.62M | ﹤0.01% |
48,400
+31,700
| +190% | +$1.82M |
|
5042
ProShares UltraPro Short Dow 30
SDOW
$174M
| $2.62M | ﹤0.01% |
+51,771
| New | +$2.55M |
|
5043
First American
FAF
$7.54B
| $2.62M | ﹤0.01% |
42,000
+14,599
| +53% | +$952K |
|
5044
Vanguard Short-Term Bond ETF
BSV
$45.7B
| $2.62M | ﹤0.01% |
33,933
-454,499
| -93% | -$35.3M |
|
5045
CALL
Cognex
CGNX
$11B
| $2.62M | ﹤0.01% |
73,100
+48,300
| +195% | +$1.89M |
|
|
LAZR
5046
CALL
DELISTED
Luminar Technologies
LAZR
| $2.62M | ﹤0.01% |
486,974
+372,381
| +325% | +$3.93M |
|
5047
Stepan Co
SCL
$1.48B
| $2.62M | ﹤0.01% |
40,463
+24,233
| +149% | +$1.79M |
|
5048
CALL
Redwire
RDW
$3.39B
| $2.62M | ﹤0.01% |
159,000
+126,400
| +388% | +$1.36M |
|
5049
PUT
Verisk Analytics
VRSK
$23.6B
| $2.62M | ﹤0.01% |
9,500
+9,300
| +4,650% | +$2.59M |
|
5050
iShares MSCI Sweden ETF
EWD
$587M
| $2.62M | ﹤0.01% |
70,054
+19,596
| +39% | +$777K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.